references/health-benchmarks.md
Org Health Benchmarks by Stage
Benchmarks for scoring each dimension at Seed, Series A, Series B, and Series C.
Financial Health Benchmarks (CFO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Runway (green) | >18mo | >12mo | >12mo | >18mo | | Runway (yellow) | 9-18mo | 6-12mo | 6-12mo | 9-18mo | | Runway (red) | <9mo | <6mo | <6mo | <9mo | | Burn multiple (green) | <3x | <2x | <1.5x | <1x | | Burn multiple (yellow) | 3-5x | 2-3x | 1.5-2.5x | 1-1.5x | | Gross margin (green) | >50% | >65% | >70% | >75% | | MoM growth (green) | >15% | >10% | >7% | >5% | | Revenue concentration | <30% | <25% | <15% | <10% |
Stage-specific notes:
- Seed: Burn multiple is looser — you're investing in PMF, not efficiency
- Series A: Efficiency starts to matter; board watching burn multiple closely
- Series B: Capital efficiency is table stakes; burn >2x raises serious questions
- Series C: Approaching path to profitability; investors expect <1.5x
Revenue Health Benchmarks (CRO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | NRR (green) | >100% | >110% | >115% | >120% | | NRR (yellow) | 90-100% | 100-110% | 105-115% | 110-120% | | NRR (red) | <90% | <100% | <105% | <110% | | Logo churn (green) | <15%/yr | <10%/yr | <7%/yr | <5%/yr | | Pipeline coverage | >2x | >3x | >3.5x | >4x | | CAC payback (green) | <24mo | <18mo | <12mo | <9mo | | Win rate (green) | >20% | >25% | >28% | >30% | | ACV trend | growing | growing | growing | growing |
What "green" NRR signals:
-
100%: product creates value; expansion outpaces churn
-
110%: customers grow inside your platform; land-and-expand working
-
120%: exceptional — net negative churn; growth from existing base alone
- <100%: customers leave faster than others expand; structural retention problem
Warning: NRR can mask problems. NRR of 110% with 25% logo churn means you're retaining revenue from large customers while losing small ones. Check both.
Product Health Benchmarks (CPO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | NPS (green) | >30 | >40 | >45 | >50 | | NPS (yellow) | 10-30 | 20-40 | 30-45 | 40-50 | | NPS (red) | <10 | <20 | <30 | <40 | | DAU/MAU (green) | >25% | >35% | >40% | >45% | | Core feature adoption | >40% | >55% | >65% | >70% | | Time-to-value | <7 days | <5 days | <3 days | <2 days | | CSAT | >4.0/5 | >4.2/5 | >4.3/5 | >4.4/5 |
PMF proxy metrics:
- "Very disappointed" if product disappeared: >40% = strong PMF signal (Sean Ellis test)
- 6-month retention cohort: >40% is healthy; <20% means PMF not yet achieved
- Organic referral rate: >20% of new users from referrals = product-led growth signal
What low DAU/MAU actually means:
- <20% DAU/MAU for a daily-use product = product isn't integrated into workflow
- DAU/MAU benchmarks vary by use case: email tool (daily use expected) vs. annual budget tool (weekly use is fine)
- Always compare to category, not absolute benchmarks
Engineering Health Benchmarks (CTO)
DORA metrics are the industry standard (Google's DevOps Research and Assessment):
| Metric | Elite | High | Medium | Low | |--------|-------|------|--------|-----| | Deployment frequency | Multiple/day | Weekly | Monthly | <Monthly | | Lead time for changes | <1 hour | 1 day-1 week | 1-6 months | >6 months | | Change failure rate | <5% | 5-10% | 10-15% | >15% | | MTTR | <1 hour | <1 day | 1 day-1 week | >1 week |
Translation for startup stages:
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Deploy freq (green) | Weekly | Daily | Daily | Multiple/day | | MTTR (green) | <4h | <2h | <1h | <30min | | Change failure rate (green) | <15% | <10% | <7% | <5% | | Tech debt ratio (green) | <30% | <25% | <20% | <15% | | P0 incidents/month (green) | <3 | <2 | <2 | <1 |
Warning signs unique to early-stage:
- Bus factor = 1 on critical systems (one person knows how it works) → immediate risk
- No on-call rotation → incidents wake the same person every time → attrition risk
- No staging environment → production is the test environment → change failure spike risk
- "We'll fix it after launch" for >12 months → tech debt is now a strategic problem
People Health Benchmarks (CHRO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Regrettable attrition (green) | <15% | <12% | <10% | <8% | | Regrettable attrition (red) | >25% | >18% | >15% | >12% | | eNPS (green) | >20 | >30 | >35 | >40 | | Time-to-fill (green) | <60d | <45d | <45d | <30d | | Internal promotion rate | >20% | >25% | >30% | >35% | | Manager span of control | 1:4-8 | 1:5-8 | 1:6-10 | 1:6-12 | | % under-performers managed out | 3-5% | 3-5% | 3-5% | 3-5% |
Regrettable vs non-regrettable attrition:
- Regrettable: you'd rehire them immediately; they leave for better opportunity
- Non-regrettable: performance-based exits; mutual agreement; role evolution
- Only regrettable attrition signals health problems
eNPS benchmarks by sector:
- Tech startups: >30 is good; >50 is exceptional
- General: >0 means more promoters than detractors (minimum bar)
- Below -10: serious cultural issue; expect more attrition
The cascade warning: People health is a leading indicator, not lagging. By the time attrition shows up in your numbers, the next wave is already decided. Watch eNPS and engagement quarterly.
Operational Health Benchmarks (COO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | OKR completion rate (green) | >60% | >70% | >75% | >80% | | Decision cycle time (green) | <3 days | <2 days | <48h | <24h | | Process maturity level | 1-2 | 2-3 | 3-4 | 4-5 | | Cross-functional delivery (on time) | >60% | >70% | >75% | >80% | | Leadership team tenure | N/A | >12mo avg | >18mo avg | >24mo avg |
OKR interpretation:
- 100% completion = OKRs were too easy (not ambitious enough)
- 60-70% completion = appropriate stretch, realistic execution
- <40% completion = disconnect between strategy and capacity, or OKRs set without buy-in
- OKRs nobody can remember = OKRs that don't guide decisions = wasted exercise
Security Health Benchmarks (CISO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Security incidents (P1+) | 0-1/yr | 0/yr | 0/yr | 0/yr | | Pen test cadence | Annual | Annual | Bi-annual | Bi-annual | | SOC 2 Type II | Roadmap | In progress | Complete | Complete | | ISO 27001 | — | Roadmap | In progress | Complete | | Security training completion | >80% | >90% | >95% | >95% | | Critical CVE patching SLA | <72h | <48h | <24h | <12h | | MFA coverage | >80% | >95% | 100% | 100% | | Employee background checks | Key roles | All | All | All |
Stage-specific compliance priorities:
- Seed: Basic hygiene (MFA, encryption, access control)
- Series A: SOC 2 Type I on roadmap; sales increasingly requiring it
- Series B: SOC 2 Type II complete; ISO 27001 if selling to enterprise/EU
- Series C: Full compliance stack; GDPR, HIPAA if applicable
Market Health Benchmarks (CMO)
| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | CAC trend | Acceptable | Improving | Improving | Stable/improving | | Organic % of pipeline | >30% | >40% | >50% | >60% | | Win rate (green) | >20% | >25% | >27% | >30% | | Competitive win rate | >40% | >45% | >50% | >55% | | Brand awareness in ICP | Low OK | Growing | Recognized | Leader | | Content-to-pipeline conversion | Tracked | >2% | >3% | >4% |
How Dimensions Interact
Understanding interdependencies helps predict cascades before they happen:
People Health degrades
↓ (60-90 day lag)
Engineering Health degrades (velocity drops, debt rises)
↓ (30-60 day lag)
Product Health degrades (features slip, quality drops)
↓ (60-90 day lag)
Revenue Health degrades (churn rises, deals stall)
↓ (30-60 day lag)
Financial Health degrades (cash gap, runway shortens)
↓ (immediate)
People Health degrades further (hiring freeze, morale)
The prevention prescription:
- Fix People and Engineering problems first — they cascade to everything
- Financial problems require immediate response (no lag)
- Revenue problems are often symptoms of Product or People problems upstream
- Security problems can cascade fast (breach → customer churn → financial → people)
Weighting by stage (for overall score):
| Dimension | Seed | Series A | Series B | Series C | |-----------|------|----------|----------|----------| | Financial | 30% | 25% | 20% | 20% | | Revenue | 20% | 25% | 25% | 25% | | People | 20% | 15% | 15% | 15% | | Product | 15% | 15% | 15% | 15% | | Engineering | 10% | 10% | 10% | 10% | | Operations | 5% | 5% | 8% | 8% | | Market | — | 5% | 5% | 5% | | Security | — | — | 2% | 2% |